Investigating gut microbiota in patients with limb lymphedema and recurrent infections
Official title: Typing of Gut Microbiota in Patients With Limb Lymphedema and Recurrent Lymphangitis, a Prospective Observational Study
Run by Fondazione Policlinico Universitario Agostino Gemelli IRCCS · NCT06228937 · Data updated 2026-11-12
This study looks at how the bacteria in the gut might be linked to limb lymphedema and repeated infections in patients to see if there are any important differences between those who have infections and those who don’t.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 85 Years |
| Sex | All |
| Enrollment | 60 (estimated) |
| Sponsor | Fondazione Policlinico Universitario Agostino Gemelli IRCCS Academic / other |
| Locations | 1 site (Rome) |
| Status | Recruiting |
| Started | February 22, 2024 |
| Main results expected | October 30, 2027 |
| Study ends | October 30, 2028 |
| Registry record updated | September 3, 2026 |
| Trial ID | NCT06228937 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18-85 with upper or lower limb lymphedema and a history of recurrent soft tissue infections.
✕Probably not a fit
Patients with conditions such as diabetes, immunodeficiency, or those currently on antibiotic therapy may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to explore the relationship between gut microbiota and limb lymphedema in patients who experience recurrent soft tissue infections. It will analyze stool samples from participants to identify pro-inflammatory changes in their microbiota. The study includes two groups: one with a history of infections and another without, both having lymphedema. By understanding these microbiota changes, the study seeks to shed light on potential underlying mechanisms of infection in lymphedema patients.
Why it matters
Potential benefit: If successful, this study could lead to new insights into managing recurrent infections in lymphedema patients, potentially improving their quality of life.
How similar studies have gone: While this approach is novel in the context of lymphedema, similar studies have shown promising results in understanding microbiota's role in other inflammatory conditions.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria (Group A): * 18-85 years * primary or secondary, upper or lower limb lymphedema, I-II-III stage ISL * at least 3 episodes of soft tissue infection in an year, in the last 2 years * consent to participate in the study Inclusion Criteria (Group B): * 18-85 years * primary or secondary, upper or lower limb lymphedema, stage I-II-III (ISL) * no episodes of soft tissue infection in the last 2 years * consent to participate in the study Exclusion Criteria: * No compliance to perform limb compression and skin hygiene * Antibiotic therapy in the last 15 days * Diabetes mellitus * Immunodeficiency * Ongoing neoplastic pathology * Taking immunosuppressive drugs * Unavailability to follow-up for at least 24 months post-enrollment.
Where it's running
-
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Rome, Italy Recruiting
Study contacts
- Principal investigator: Stefano Gentileschi — Fondazione Policlinico Universitario Agostino Gemelli IRCCS
- Study coordinator: Stefano Gentileschi
- Email: stefano.gentileschi@policlinicogemelli.it
- Phone: +390630151
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Use of reconstructive microsurgery to treat lymphedema
This study tests whether reconstructive microsurgery, with or without the help of indocyanine green imaging, can help people with lymphedema feel and function better by improving lymphatic drainage.
-
Predicting lymphedema risk in inflammatory breast cancer patients using preoperative body impedance analysis
This study tests whether a preoperative bioimpedance test can help identify IBC patients who are at risk for developing lymphedema.
-
Inulin Prebiotic for Perimenopausal Women with Overweight or Obesity
This study tests whether 2 weeks of inulin can affect gut and vaginal microbes, heart health, and muscle health in perimenopausal women who are overweight or obese, using a crossover design.
-
Boosted compression for lower limb edema
This study tests whether applying a multicomponent short-stretch bandage three times daily (boosted compression) helps reduce edema faster in people with chronic edema or lymphedema of the legs, compared with the standard single daily bandage.
-
Health effects of ultra-processed foods on appetite and cardiometabolic health
This study tests whether a high ultra-processed food diet affects appetite and cardiometabolic health compared with a nutrient-matched low ultra-processed diet in adults who keep their weight stable.
-
Erector Spinae Block vs Paravertebral Block for Chronic Pain After Mastectomy
This trial tests whether an erector spinae block can better prevent chronic pain after mastectomy than a paravertebral block in adults 18–80.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.